About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Understanding Hallucinations (Part I) | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT01907568

Understanding Hallucinations (Part I)

Psychotic symptoms (hallucinations and delusions) are present in several psychiatric and neurological disorders as well as in the general population. Effective treatment strategies for these symptoms ...

Lead sponsor: UMC Utrecht•4 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Mascha M.J. Linszen, MD

CONTACT

+31887557468 m.m.j.linszen@umcutrecht.nl

Sophie M. Heringa, PhD

CONTACT

s.m.heringa@umcutrecht.nl

Sponsors

Lead Sponsor

UMC Utrecht

Collaborators

University Medical Center Groningen
Universitair Ziekenhuis Brussel
Parnassia Groep

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•age \> 18 years
•mentally competent
•in case of delirium: family member able to give informed consent
•Individuals with hallucinations will have to experience at least one episode of hallucinations over the last month.
•Individuals without hallucinations: no current hallucinations and a history of maximum 1 episode of hallucinations with a maximum duration of 1 week, at least two years ago.

Exclusion Criteria

•Age \<18)
•Participants that cannot read, speak or understand Dutch
•For all included diagnostic groups except delirium: Mentally incompetent individuals who are not capable to provide informed consent, as determined by their treating physician.

Related studies

Role of Inferior Colliculi in Auditory Hallucinations

NCT07003529 · Schizophrenia, Hallucinations, Auditory

Cognitive and Metacognitive Evaluation in VR-Based Avatar Therapy for Psychosis

NCT07091344 · Schizophrenia Disorders, Treatment Resistant Hallucinations

VR-based Avatar Therapy for Treatment of Auditory Hallucinations

NCT06505564 · Hallucinations, Auditory, Schizophrenia Spectrum and Other Psychotic Disorders

Active Not RecruitingPhase 2

Trial of Ondansetron as a Parkinson's HAllucinations Treatment

NCT04167813 · Parkinson's Hallucinations, Dementia With Lewy Bodies

Not Yet RecruitingNA

Cost-utility Study of Cognitive-behavioral Management of Auditory Hallucinations in Schizophrenic Disorder

NCT07134816 · Auditory Hallucinations, Schizophrenia Spectrum

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 26, 2016Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment700

Start dateJun 2013

Last updatedOct 26, 2016

Condition

Hallucinations No Hallucinations

Locations shown

VU Medical Center

Amsterdam

UMC Groningen

Groningen

Parnassia Bavo Groep

The Hague

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 26, 2016Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions